SGAM
EW icon

Steinberg Global Asset Management’s Edwards Lifesciences EW Stock Holding History

Steinberg Global Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$423K Buy
+6,630
New +$378K 0.07% 199
2018
Q4 		– Sell
-3,600
Closed -$209K – 235
2018
Q3 		$209K Buy
+3,600
New +$176K 0.03% 231

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Steinberg Global Asset Management's EW Position: Q1 2019 in Review

Steinberg Global Asset Management opened a new position in Edwards Lifesciences (EW) in Q1 2019: 6,630 shares worth $423K. The stake represents 0.07% of the portfolio and ranks #199 among its holdings. This is a return to the name: Steinberg Global Asset Management previously reported a position in EW as recently as Q3 2018.

Steinberg Global Asset Management first reported a position in EW in Q3 2018 and has held it in 2 quarters since. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • Steinberg Global Asset Management held 6,630 shares of Edwards Lifesciences worth $423K as of Q1 2019.
  • Edwards Lifesciences was a new Steinberg Global Asset Management position in Q1 2019.
  • Edwards Lifesciences made up 0.07% of Steinberg Global Asset Management's portfolio in Q1 2019, its #199 holding.
  • Steinberg Global Asset Management first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 2 quarters since.
  • 922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Steinberg Global Asset Management's 13F filing for Q1 2019, filed 15 Apr 2019.